4 completed, 2 recruiting, 1 unknown. 4 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Recruiting 1, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow Mucosal Immunity: new trials by email Literature Review of Mucosal Immunity trials Research Report on Mucosal Immunity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neutralizing Power of Serum Antibodies - 2 Sample collection (blood and optional nasal swab) - COVID-19, SARS-CoV-2 Viraemia | Not applicable | Recruiting | Centre Hospitalier Régional d'Orléans | 30 | 2025-08-22 | 2025-12-19 |
| Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before and After a Race Intervention Name: Fermented milk containing Lacticaseibacillus paracasei strain Shirota. Intervention Name: Non-fermented milk (placebo), Non-fermented milk (placebo) - Respiratory Tract Infections (RTI), Mucosal Immunity | Not applicable | Completed | Federal University of São Paulo | 80 | 2025-08-13 | 2026-10-15 |
| Multi-Strain Probiotic Supplementation, Salivary Immunity, and Upper Respiratory Symptoms in Trained Athletes Multi-Strain Probiotic, Rice Flour Placebo - Upper Respiratory Symptoms, Mucosal Immunity | Not applicable | Completed | University of Ulster | 15 | 2025-05-13 | 2026-08-24 |
| To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children Respiratory Tract Infections (RTI), Mucosal Immunity | Recruiting | Desmond Tutu TB Centre | 250 | 2024-10-23 | 2025-03-30 | |
| Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848) R848, Saline - Innate Immunity, Mucosal Immunity | Not applicable | Unknown | Akhilesh Jha | 36 | 2024-05-24 | 2024-07-10 |
| Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study No intervention - SARS-CoV-2 Infection, Influenza Viral Infections | Completed | University Hospital, Geneva | 320 | 2023-01-10 | 2025-01-14 | |
| Strategies for Enhancing Mucosal Immunity to Influenza Vaccine Fluzone - Mucosal Immunity | Early Phase 1 | Completed | John Sundy | 60 | 2011-04-01 | 2012-12-06 |
COVID-19 (2) · Respiratory Tract Infections (2) · Signs and Symptoms, Respiratory (2) · Asthma (1) · Depressive Disorder (1) · Inflammation (1) · Motor Activity (1) · Mpox, Monkeypox (1) · Psychological Well-Being (1) · Respiratory Syncytial Virus Infections (1) · Virus Diseases (1)
Infections (5) · Respiratory Tract Diseases (5) · Lung Diseases (3) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Nidovirales Infections (2) · Pathological Conditions, Signs and Symptoms (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Infections (2) · Signs and Symptoms (2) · Virus Diseases (2) · Animal Diseases (1) · Behavior (1)
Blood Specimen Collection (1) · Influenza Vaccines (1) · Sodium Chloride (1) · Specimen Handling (1) · resiquimod (1)
Akhilesh Jha (1) · Centre Hospitalier Régional d'Orléans (1) · Desmond Tutu TB Centre (1) · Federal University of São Paulo (1) · John Sundy (1) · University Hospital, Geneva (1) · University of Ulster (1)
United Kingdom (2) · Brazil (1) · France (1) · South Africa (1) · Switzerland (1) · United States (1)
Andrea McNeilly, PhD (1) · Benjamin Meyer, Dr. (1) · John Sundy, MD, PhD (1) · Marieke van der Zalm, PhD (1) · Mauro W Vaisberg, PHD (1)